Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT03769298 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

CIRTEN-Simultaneous Pancreas-Kidney Transplant Recipients

StatusRecruiting
PhasePhase 2/3
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Site contact updatedv20
  2. Enrollment target: 30 to 20
    • Primary and study completion dates: Dec 2025 to Dec 2026
    • Study description revised
    v19
  3. Re-verified, no change to tracked fieldsv18
  4. Primary completion date: Dec 31, 2023 to Dec 2025
    • Study completion date: Dec 31, 2024 to Dec 2025
    v17
  5. Re-verified, no change to tracked fieldsv16
Show 14 earlier versionsHide 14 earlier versions
  1. Primary completion date: Oct 31, 2022 to Dec 31, 2023
    • Study completion date: Oct 31, 2022 to Dec 31, 2024
    v15
  2. 2 versions Re-verified since Mar 8, 2021, no change to tracked fieldsv13-v14
  3. Trial status: Suspended to Recruiting
    • Site details revised
    v12
  4. Re-verified, no change to tracked fieldsv11
  5. Trial status: Recruiting to Suspended Sponsor's reason: Due to COVID-19
    • Site details revised
    v10
  6. Study description revised
    • Eligibility criteria expanded, about 4 words
    v9
  7. Site contact updatedv8
  8. Start date changed from estimate of Mar 5, 2019 to Feb 27, 2019v7
  9. Start date: Feb 25, 2019 to Mar 5, 2019v6
  10. Start date: Feb 15, 2019 to Feb 25, 2019v5
  11. Start date: Feb 1, 2019 to Feb 15, 2019v4
  12. Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 0 to 1
    • Start date: Jan 21, 2019 to Feb 1, 2019
    v3
  13. Primary endpoints revised (4)
    • Start date: Jan 1, 2019 to Jan 21, 2019
    • Study description shortened, about 4 words
    v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This is a Phase II/III, Single-center, Prospective, Open-label, Single Arm Study of 20 Simultaneous Kidney Pancreas recipients who received a transplant at least 3 months, but no more than 5 years prior, with a history of tremors following transplantation.
Trial Details
NCT Number NCT03769298
Lead Sponsor University of Wisconsin, Madison
Collaborators: Veloxis Pharmaceuticals
Conditions
(from sponsor)		 Kidney Pancreas Transplantation
Related terms Tremor
Enrollment 20 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov